Annemarie C. de Vries

Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn’s disease patients with prior failure to anti‐TNF treatment

Vince Biemans, C. Janneke van der Woude, Gerard Dijkstra et al. · Alimentary Pharmacology & Therapeutics · 2020 · 129 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases

Kate D. Lynch, Roger W. Chapman, Satish Keshav et al. · Clinical Gastroenterology and Hepatology · 2019 · 101 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry

Vince Biemans, Jasmijn A M Sleutjes, Annemarie C. de Vries et al. · Alimentary Pharmacology & Therapeutics · 2020 · 87 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Decreasing Trends in Intestinal Resection and Re-Resection in Crohn's Disease

Evelien Beelen, C. Janneke van der Woude, Marie J. Pierik et al. · Annals of Surgery · 2019 · 48 citations · Full text

Medicine, Pathology, Surgery +14

High Immunogenicity to Influenza Vaccination in Crohn’s Disease Patients Treated with Ustekinumab

Laura Doornekamp, Rogier Goetgebuer, Katharina S. Schmitz et al. · Vaccines · 2020 · 45 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17